Doctor Karola Jering
Brigham and Women's Hospital, Boston (United States of America)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial
Event: ESC Congress 2024
Topic: Biomarkers
Session: Diagnostic and prognostic performance of cardiac troponin
Differences in risk profiles and clinical outcomes according to age in patients with high-risk myocardial infarction: insights from the PARADISE-MI trial
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Risk stratification models after acute coronary syndrome
Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Troponin and other biomarkers in acute coronary syndromes
Pulmonary hypertension in heart failure with preserved ejection fraction: the TOPCAT Americas and PARAGON-HF studies
Event: Heart Failure 2021
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Chronic Heart Failure - Pathophysiology and Mechanisms 1
